Literature DB >> 11748584

Proteoglycans of the extracellular matrix and growth control.

H Kresse1, E Schönherr.   

Abstract

Regulated cell growth results from the biological balance between soluble growth-regulating factors, their receptors and the elicited signal cascade on the one hand side and from extracellular macromolecular components and their interplay with membrane receptors on the other side. Proteoglycans have recently been recognized not only to play a part in providing shape and biomechanical strength of organs and tissues, but also to exhibit direct and indirect cell signalling properties. In this review, we discuss the direct growth-regulating role of proteoglycans with special emphasis on the lectican family and on the family of small proteoglycans with leucine-rich repeats (SLRPs). Indirect actions of proteoglycans by modulation of growth factor activities and growth factor distribution are exemplified by discussing the TGF-beta-binding properties of SLRPs and the interactions of core proteins of matrix proteoglycans with other growth factors. It is emphasized that the modulatory role of proteoglycans on cell proliferation cannot be separated from their participation in tissue organization in general, thereby explaining the diverse and sometimes contradictory reports on the effects of proteoglycans on cell proliferation and differentiation. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11748584     DOI: 10.1002/jcp.10030

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  87 in total

1.  The mechanism of mimecan transcription induced by glucocorticoid in pituitary corticotroph cells.

Authors:  Xiao Na Zhang; Li Qiong Xue; He Jiang; Shao Ying Yang; Huai Dong Song; Qin Yun Ma
Journal:  Mol Cell Biochem       Date:  2011-09-22       Impact factor: 3.396

2.  Mouse resistin modulates adipogenesis and glucose uptake in 3T3-L1 preadipocytes through the ROR1 receptor.

Authors:  Beatriz Sánchez-Solana; Jorge Laborda; Victoriano Baladrón
Journal:  Mol Endocrinol       Date:  2011-11-10

3.  In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells.

Authors:  Gabriela Dontu; Wissam M Abdallah; Jessica M Foley; Kyle W Jackson; Michael F Clarke; Mari J Kawamura; Max S Wicha
Journal:  Genes Dev       Date:  2003-05-15       Impact factor: 11.361

4.  The ECM proteoglycan decorin links desmoplasia and inflammation in chronic pancreatitis.

Authors:  J Köninger; N A Giese; M Bartel; F F di Mola; P O Berberat; P di Sebastiano; T Giese; M W Büchler; H Friess
Journal:  J Clin Pathol       Date:  2006-01       Impact factor: 3.411

5.  Primate embryonic stem cells create their own niche while differentiating in three-dimensional culture systems.

Authors:  M Michelini; V Franceschini; S Sihui Chen; S Papini; A Rosellini; F Ciani; L Margolis; R P Revoltella
Journal:  Cell Prolif       Date:  2006-06       Impact factor: 6.831

Review 6.  CS lyases: structure, activity, and applications in analysis and the treatment of diseases.

Authors:  Robert J Linhardt; Fikri Y Avci; Toshihiko Toida; Yeong Shik Kim; Miroslaw Cygler
Journal:  Adv Pharmacol       Date:  2006

7.  Decorin-mediated regulation of fibrillin-1 in the kidney involves the insulin-like growth factor-I receptor and Mammalian target of rapamycin.

Authors:  Liliana Schaefer; Wasiliki Tsalastra; Andrea Babelova; Martina Baliova; Jens Minnerup; Lydia Sorokin; Hermann-Josef Gröne; Dieter P Reinhardt; Josef Pfeilschifter; Renato V Iozzo; Roland M Schaefer
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

Review 8.  The role of decorin in collagen fibrillogenesis and skin homeostasis.

Authors:  Charles C Reed; Renato V Iozzo
Journal:  Glycoconj J       Date:  2002 May-Jun       Impact factor: 2.916

Review 9.  Biglycan knockout mice: new models for musculoskeletal diseases.

Authors:  Marian F Young; Yanming Bi; Laurent Ameye; Xiao-Dong Chen
Journal:  Glycoconj J       Date:  2002 May-Jun       Impact factor: 2.916

10.  Decorin inhibits the proliferation of HepG2 cells by elevating the expression of transforming growth factor-β receptor II.

Authors:  Yanfeng Liu; Xuesong Wang; Zhaohui Wang; Wenbo Ju; Dawei Wang
Journal:  Exp Ther Med       Date:  2016-08-04       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.